FNA: Rega marang dodolan Paragon 28 Inc.
Paragon 28, Inc. (FNA) is expanding through new surgical solutions and the shift of procedures to the outpatient sector. The current price-to-sales ratio reflects the market valuation of the business, where 4.30 is the current value of the metric. The company's economics rely on the mass production of high-margin titanium products, while the intensive development of robotic systems and orthopedic fixators ensures a technological breakthrough.
Rincian analitis perusahaan Paragon 28, Inc. (FNA)
- rega pasar lan target rega analis:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Rasio Total Utang marang Ekuitas Paragon 28, Inc.|FNA - Utang jangka dawa marang modal|Utang jangka cendhak marang modal paragon28.com|FNA - Utang perusahaan|Rasio utang marang kapitalisasi buku Paragon 28 Corp|FNA - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Paragon 28|Likuiditas darurat paragon28.com
- indikator pendapatan resik lan kelipatan nilai:
FNA - Bathi resik perusahaan|Proyeksi bathi resik Paragon 28, Inc.|FNA - Koefisien rega marang bathi|Pangali Forward P/E paragon28.com|FNA - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Paragon 28 Corp|FNA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan Paragon 28|FNA - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan paragon28.com|FNA - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Paragon 28, Inc.
- rincian pendapatan lan dodolan emiten:
Analisis fundamental perusahaan:Paragon 28 Inc. FNA
The multiplier assesses the market value of the business relative to its annual revenue, allowing the investor to identify asset undervaluation through an analysis of the price-to-sales ratio. This coefficient is calculated by dividing the market capitalization of Paragon 28, Inc. (FNA) by its sales volume, reflecting the monetization efficiency of innovative orthopedic solutions and the effectiveness of the sales staff incentive system.
Karo sapa Paragon 28, Inc. saingan
Kapitalisasi marang pendapatan bostonscientific.com BSX|Multiplikator P/S EW (Edwards Lifesciences Corporation)|ResMed Inc (RMD) - Rega marang dodolan|OmniPod - Multiplikator P/S|ZBH (Zimmer Biomet Holdings) - Rasio kapitalisasi marang pendapatan|COO: Multiplikator P/S|ALGN - Koefisien rega marang pendapatan|GMED (Globus Medical) - Multiplikator P/S|Kapitalisasi marang pendapatan TransMedics Group Inc (TMDX)|Multiplikator P/S ATEC|Multiplikator P/S Artivion Corp (AORT)|Rasio rega marang pendapatan Enovis Corporation ENOV|integralife.com - Rasio rega marang pendapatan|ESTA: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan BBNX (Beta Bionics, Inc.)|IRMD: Multiplikator P/S|Rega marang dodolan Embecta Health (EMBC)|Rasio rega marang pendapatan Tandem Diabetes Care|AXGN - Multiplikator rega marang pendapatan|Kapitalisasi marang pendapatan SIBN (SI-BONE)|Multiplikator P/S Orthofix Medical (OFIX)|Multiplikator P/S BVS (Bioventus Corp)|Koefisien rega marang pendapatan OrthoPediatrics Corp (KIDS)|TMCI - Rasio rega marang pendapatan|Rasio rega marang dodolan SRTA|Carlsmed (CARL) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan RxSight Inc|CLPT (ClearPoint Neuro Inc.) - Multiplikator P/S|Rega marang dodolan Stereotaxis Corporation STXS|Rasio rega marang pendapatan Neuronetics, Inc. (STIM)|sightsciences.com - Rasio kapitalisasi marang pendapatan|Orchestra BioMed, Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan ANIK (Anika Therapeutics Inc.)|NSPR - Rasio rega marang pendapatan|Rasio rega marang dodolan ZJYL|VANI: Multiplikator P/S|Xtant Medical (XTNT) - Multiplikator P/S|Rasio rega marang pendapatan NeuroOne Medical Technologies Corporation|MODD: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S MYO|Multiplikator P/S Envoy Medical Inc (COCH)|Multiplikator P/S VVOS (Vivos Therapeutics)|Multiplikator rega marang pendapatan envveno.com|SINT - Rasio rega marang pendapatan|Rega marang dodolan Tenon Medical Inc.|ReWalk Robotics Ltd (LFWD) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan AMIX|Kapitalisasi marang pendapatan IVF|BBLG: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Axonics (AXNX)|BIOL (BIOLASE Inc.) - Rasio kapitalisasi pasar marang pendapatan|Dynatronics - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan INVO
